TRK-A Expression in Neuroblastomas: A New Prognostic Marker With Biological and Clinical Significance
β Scribed by Brodeur, G. M.
- Book ID
- 111867993
- Publisher
- Oxford University Press
- Year
- 1993
- Tongue
- English
- Weight
- 208 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0027-8874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Neuroblastomas (NBs) exhibit a wide variety of clinical behavior. It is important to determine the biology of NB before treatment is instituted. ## METHODS. One hundred six NBs detected clinically (clinical NBs) were classified according to immunohistochemical expression of the H
## Abstract ## BACKGROUND. Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin tumor, mostly affecting elderly individuals. The histogenesis of this rare tumor as well as its prognostic criteria are a matter of dispute. ## METHODS. An immunohistochemical analysis of markers of proli
## Abstract The clinical management of locoregional neuroblastoma (LR NB) is controversial. In a previous study we showed that diploidy was a strong prognostic predictor of outcome and detected the existence of clonal ploidy heterogeneity in a select group of cases. The aims of this study were (1)
We are now beginning to understand the development of bladder cancer at the molecular level. Tumor evolution involves the interaction of both oncogenes and tumor suppressor genes. One of the key tumor suppressor genes in this process is the retinoblastoma (RB) gene. Much has been learned recently ab